IBIO
iBio, Inc.
Key Financials
Gross Profit
$2.2M
↑ 138.4%
Operating Income
$-18602000
↓ 11.8%
Net Income
$-18377000
↑ 26.2%
Revenue
$400000
↑ 77.8%
Total Liabilities
$8.3M
↑ 12.1%
EPS (Diluted)
$-1.75
↑ 73.1%
Total Assets
$23.2M
↓ 19.3%
Cash & Equivalents
$8.6M
↓ 39.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | IBIO |
| Company Name | iBio, Inc. |
| CIK | 1420720 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 0630 |
| State of Incorporation | DE |
| Phone | 302 355-0650 |